Axsome Therapeutics Inc (AXSM) financials · rev $638.5M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Axsome Therapeutics Inc (AXSM) rev $638.5M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $638.5M | $385.7M |
| Operating Income | -$166.8M | -$280.6M |
| Net Income | -$183.2M | -$287.2M |
| EPS (Diluted) | -$3.68 | -$5.99 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $689.8M | $568.5M |
| Current Assets | $589.0M | $485.1M |
| Cash & Equivalents | $322.9M | $315.4M |
| Inventory | $27.9M | $15.7M |
| PP&E | $562.0K | $584.0K |
| Total Liabilities | $601.5M | $511.5M |
| Current Liabilities | $378.8M | $230.1M |
| Short-term Debt | $70.0M | N/A |
| Long-term Debt | $117.7M | $180.7M |
| Total Debt | $187.7M† | $180.7M† |
| Shareholders' Equity | $88.3M | $57.0M |
| Retained Earnings | -$1.31B | -$1.12B |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$93.4M | -$128.4M |
| CapEx | $480.0K | $270.0K |
| Investing Cash Flow | -$480.0K | -$270.0K |
| Financing Cash Flow | $101.5M | $57.8M |
| Net Change in Cash | $7.58M | -$70.8M |
| Free Cash Flow | -$93.9M | -$128.7M |
FAQ
What is AXSM P/E and revenue?
Axsome Therapeutics Inc (AXSM) rev $638.5M.
What is AXSM revenue?
Axsome Therapeutics Inc last cached revenue is $638.5M (FY2025).
Is AXSM profitable?
Axsome Therapeutics Inc last cached net income is -$183.2M (FY2025).
What are AXSM total assets?
Axsome Therapeutics Inc last cached total assets are $689.8M (FY2025).
What is AXSM free cash flow?
Axsome Therapeutics Inc last cached free cash flow is -$93.9M (FY2025).
Not investment advice. Cached statements, not a live tape.